These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 38636433)
1. Inhibition of TGF-β1/Smad3 signaling by compound 5aa: A potential treatment for idiopathic pulmonary fibrosis. An B; Fang Y; Wang L; Nie W; Wang M; Nie H; Wu C; Wang R Bioorg Chem; 2024 Jun; 147():107374. PubMed ID: 38636433 [TBL] [Abstract][Full Text] [Related]
2. USP7 Promotes TGF-β1 Signaling by De-Ubiquitinating Smad2/Smad3 in Pulmonary Fibrosis. Tang F; Gong H; Ke T; Yang W; Yang Y; Liu Z Discov Med; 2024 Aug; 36(187):1616-1626. PubMed ID: 39190377 [TBL] [Abstract][Full Text] [Related]
4. ESL attenuates BLM-induced IPF in mice: Dual mediation of the TLR4/NF-κB and TGF-β1/PI3K/Akt/FOXO3a pathways. Jia C; Yang M; Xiao G; Zeng Z; Li L; Li Y; Jiang J; Xu A; Qiu J; Tang R; Li D; Jia D; Xie C; Wu G; Cai D; Bi X Phytomedicine; 2024 Sep; 132():155545. PubMed ID: 38972238 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of AHNAK nucleoprotein 2 alleviates pulmonary fibrosis by downregulating the TGF-β1/Smad3 signaling pathway. Zhu D; Zhang Q; Li Q; Wang G; Guo Z J Gene Med; 2022 Sep; 24(9):e3442. PubMed ID: 35882062 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and discovery of 2(1H)-quinolone derivatives for the treatment of pulmonary fibrosis through inhibition of TGF-β/smad dependent and independent pathway. Xue L; Deng D; Zheng S; Tang M; Yang Z; Pei H; Chen Y; Yang T; Liu K; Ye H; Chen L Eur J Med Chem; 2020 Jul; 197():112259. PubMed ID: 32334267 [TBL] [Abstract][Full Text] [Related]
7. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway. Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376 [TBL] [Abstract][Full Text] [Related]
8. Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib. Bourne MH; Kottom TJ; Hebrink DM; Choudhury M; Leof EB; Limper AH Cells; 2021 Dec; 10(12):. PubMed ID: 34944010 [TBL] [Abstract][Full Text] [Related]
9. Leech extract alleviates idiopathic pulmonary fibrosis by TGF-β1/Smad3 signaling pathway. Zhang Y; Lu YB; Zhu WJ; Gong XX; Qian R; Lu YJ; Li Y; Yao WF; Bao BH; Zhang Y; Zhang L; Cheng FF J Ethnopharmacol; 2024 Apr; 324():117737. PubMed ID: 38228229 [TBL] [Abstract][Full Text] [Related]
10. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway. Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758 [TBL] [Abstract][Full Text] [Related]
11. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats. Song X; Liu W; Xie S; Wang M; Cao G; Mao C; Lv C Lab Invest; 2013 Nov; 93(11):1219-31. PubMed ID: 24042439 [TBL] [Abstract][Full Text] [Related]
12. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity. Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis. Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493 [TBL] [Abstract][Full Text] [Related]
14. Neohesperidin inhibits TGF-β1/Smad3 signaling and alleviates bleomycin-induced pulmonary fibrosis in mice. Guo J; Fang Y; Jiang F; Li L; Zhou H; Xu X; Ning W Eur J Pharmacol; 2019 Dec; 864():172712. PubMed ID: 31586469 [TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel Pleuromutilin derivative as anti-IPF lead compound via high-throughput assay. Zhang K; Liang J; Wang N; Li N; Jiang Y; Li X; Yang C; Zhou H; Yang G Eur J Med Chem; 2022 Nov; 241():114643. PubMed ID: 35961069 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and discovery of a drug candidate for treatment of idiopathic pulmonary fibrosis through inhibition of TGF-β1 pathway. Li X; Lu C; Liu S; Shuaishuai Liu ; Su C; Xiao T; Bi Z; Sheng P; Huang M; Liu X; Wei Y; Zhao L; Miao S; Mao J; Huang K; Gao S; Liu N; Qi M; Liu T; Qin S; Wei L; Sun T; Ning W; Yang G; Zhou H; Yang C Eur J Med Chem; 2018 Sep; 157():229-247. PubMed ID: 30096654 [TBL] [Abstract][Full Text] [Related]
17. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats. Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140. Wang X; Cheng Z; Dai L; Jiang T; Jia L; Jing X; An L; Wang H; Liu M Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988156 [TBL] [Abstract][Full Text] [Related]
19. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658 [TBL] [Abstract][Full Text] [Related]
20. Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation. Wang C; Song X; Li Y; Han F; Gao S; Wang X; Xie S; Lv C PLoS One; 2013; 8(8):e70725. PubMed ID: 23967091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]